Splice variant V1 of HYAL4 causes Gemcitabine resistance and predicts Gemcitabine/ Cisplatin failure in metastatic bladder cancer

Autor:	Soum D. Lokeshwar, M. J. P. Hennig, S.L. Hasanali, Vinata B. Lokeshwar, M.C. Hupe, D.S. Morera, S. Sarcan, Axel S. Merseburger, Martha K. Terris
Rok vydání:	2021
Předmět:	Metastatic bladder cancer business.industry Urology Alternative splicing Cancer research Gemcitabine/cisplatin Gemcitabine resistance Medicine business
Zdroj:	European Urology. 79:S631
ISSN:	0302-2838
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::896eb05049c979115bed6aa86881424a https://doi.org/10.1016/s0302-2838(21)00839-3 Zobrazit plný text záznamu Full Text from ScienceDirect